Previous Nav
Net Change on 24-11-2023
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Cipla Ltd.
Dr. Reddy's Laboratories Ltd.
Apollo Hospitals Enterprise Ltd.
Lupin Ltd.
Aurobindo Pharma Ltd.
Alkem Laboratories Ltd.
FDC Ltd.
Krsnaa Diagnostics Ltd.
Aster DM Healthcare Ltd.
Fortis Healthcare Ltd.
Zydus Lifesciences Ltd.
Divi's Laboratories Ltd.
Vijaya Diagnostic Centre Pvt Ltd.
Biocon Ltd.
Glaxosmithkline Pharmaceuticals Ltd.
TREPS
IPCA Laboratories Ltd.
Torrent Pharmaceuticals Ltd.
Piramal Pharma Ltd.
Dishman Carbogen Amcis Ltd.
Mankind Pharma Ltd
SBI Life Insurance Company Ltd.
Thyrocare Technologies Ltd.
Indoco Remedies Ltd.
Glenmark Pharmaceuticals Ltd.
Viatris Inc.
HDFC Life Insurance Company Ltd.
Laxmi Organic Industries Ltd.
Eris Lifesciences Ltd.
Ajanta Pharma Ltd.
Windlas Biotech Ltd.
Advanced Enzyme Technologies Ltd.
Yatharth Hospital & Trauma Care Services Pvt Ltd
Syngene International Ltd.
Orchid Pharma Ltd.
Natco Pharma Ltd.
Healthcare Global Enterprises Ltd.
Jupiter Life Line Hospitals Ltd
Blue Jet Healthcare Ltd.
182 Days Treasury Bills
Alembic Pharmaceuticals Ltd.
Metropolis Healthcare Ltd.
ICICI Lombard General Insurance Company Ltd.
Narayana Hrudayalaya Ltd.
Cash Margin - Derivatives
Net Current Assets
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Insurance
Miscellaneous
Chemicals
Cash
Equity
SOV
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹3,270.55 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.
The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended up ₹0.11(0.43%)yesterday to ₹25.5.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .
One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051